Table 3. Summary the results of the total and subgroup analyses in different genetic models.

Variables	AA + AG vs. GG			AA vs. AG + GG			AA vs. GG			AG vs. GG			A vs. G
	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P
Total	1.33	1.17–1.51	<0.001	1.28	1.11–1.47	0.001	1.43	1.24–1.65	<0.001	1.35	1.19–1.54	<0.001	1.26	1.14–1.40	<0.001
Ethnicities
Caucasian	1.07	0.98–1.16	0.15	1.03	0.82–1.29	0.81	1.07	0.85–1.35	0.55	1.10	1.00–1.21	0.05	1.07	1.00–1.15	0.06
Asian	1.63	1.34–1.98	<0.001	1.42	1.05–1.93	0.02	1.71	1.28–2.30	<0.001	1.58	1.28–1.95	<0.001	1.45	1.25–1.68	<0.001
Mixed	1.21	0.87–1.69	0.26	0.92	0.25–3.34	0.90	0.82	0.37–1.81	0.62	1.28	0.90–1.82	0.16	1.11	0.83–1.47	0.48
Types
Breast cancer	1.26	1.11–1.44	<0.001	1.21	0.93–1.59	0.16	1.36	1.03–1.79	0.03	1.26	1.10–1.44	<0.001	1.20	1.08–1.33	<0.001
Gynaecological cancer	0.98	0.83–1.16	0.81	1.36	0.93–1.99	0.12	1.36	0.92–2.01	0.13	0.94	0.79–1.12	0.52	1.03	0.89–1.18	0.71
Urologic cancer	1.56	1.32–1.85	<0.001	1.34	0.75–2.38	0.32	1.62	0.97–2.69	0.06	1.46	1.10–1.93	<0.001	1.31	1.09–1.57	<0.001
Digestive system cancer	1.25	0.79–1.98	0.34	0.83	0.55–1.27	0.40	0.88	0.57–1.35	0.55	1.38	0.82–2.33	0.23	1.26	0.80–1.97	0.32
Hematologic malignancy	1.17	0.97–1.41	0.09	0.95	0.57–1.59	0.98	1.06	0.63–1.78	0.83	1.29	1.04–1.59	0.02	1.18	0.99–1.40	0.07
Lung cancer	1.80	1.36–2.39	<0.001	2.24	1.41–3.57	<0.001	2.86	1.75–4.69	<0.001	1.62	1.20–2.18	<0.001	1.65	1.34–2.04	<0.001
Head and neck cancer	1.3	0.68–2.48	0.43	0.76	0.40–1.46	0.41	0.92	0.47–1.80	0.81	1.35	0.70–1.61	0.37	1.16	0.71–1.91	0.55

OR = odds ratio; CI = confidence interval.